Obesity

Countries such as US and Mexico that have longer hours also have higher obesity rates, research findsThose who work longer hours are more likely to be obese and cutting how much time you spend working could help you keep the weight off, research suggests.International research presented at the European Congress on Obesity in Istanbul compared working patterns and obesity prevalence for 33 OECD countries from 1990 to 2022. The study found that countries such as the US, Mexico and Colombia, which have longer annual working hours, also had higher obesity rates, even though northern European countries consume more energy and fat on average than those in Latin America. Continue reading...

Data tool could help NHS prioritise who gets access to limited weight-loss medication, say scientistsA new tool that can shed light on who is most at risk of obesity-related diseases could help identify people who would benefit most from weight-loss medications, researchers have said.Recent data suggests about two-thirds of adults in England are overweight or obese – a situation that has caused concern among health experts. Continue reading...

• CDC reports released in February 2026 show U.S. childhood and teen obesity rates have reached record levels, marking a significant public health concern for younger populations. • The same reports indicate adult obesity rates appear to be plateauing or slowing their growth trajectory, suggesting different demographic trends across age groups. • The findings underscore ongoing disparities in metabolic health across generations and highlight the need for targeted prevention and intervention strategies.

• Recent research links extreme heat exposure, gaps in obesity coaching, cancer treatment delays, ACA premium cost spikes, and income inequality to widening health disparities across the US. • These factors exacerbate vulnerabilities in underserved populations, with global implications but focused US data. • Findings underscore needs for targeted interventions in public health equity amid rising climate and economic pressures.

GLP-1 drugs, once primarily used for diabetes treatment, have demonstrated impressive effectiveness in treating obesity, which affects over 100 million Americans, according to PBS NewsHour reporting. The class of medications is generating significant clinical interest as researchers explore both the therapeutic benefits and potential risks associated with their use. Medical experts including Dr. Jody Dushay, Dr. Rekha B. Kumar, Dr. Anna Lembke, and Dr. Ziyad Al-Aly discussed the promise of these drugs alongside concerns about safety and long-term outcomes in recent coverage.

Recent research examined by Mad in America reveals significant connections between psychiatric diagnoses, psychotropic drug use, and increased risk factors for obesity and diabetes, highlighting gaps in current screening practices. The studies indicate that individuals receiving psychiatric treatment face elevated metabolic health risks, yet comprehensive screening protocols often fail to adequately address these connections. The findings underscore the need for integrated healthcare approaches that monitor and manage both mental health conditions and associated metabolic complications in psychiatric patients.